MedPath

Altoida

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.

Completed
Conditions
MCI
Alzheimer Disease
First Posted Date
2024-01-25
Last Posted Date
2025-02-19
Lead Sponsor
Altoida
Target Recruit Count
614
Registration Number
NCT06223438
Locations
🇺🇸

K2 Medical Research South Orlando, Orlando, Florida, United States

Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures

Recruiting
Conditions
Mild Cognitive Impairment
Alzheimer's Disease
First Posted Date
2021-12-10
Last Posted Date
2023-09-29
Lead Sponsor
Altoida
Target Recruit Count
3500
Registration Number
NCT05153941
Locations
🇬🇷

Nikaia Ag Panteleimon Hospital, Athens, Greece

Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)

Not Applicable
Completed
Conditions
Alzheimer Disease
Presymptomatic Disease
Dementia
Memory Disorders
Mild Cognitive Impairment
Cognitive Impairment
First Posted Date
2016-07-26
Last Posted Date
2024-08-23
Lead Sponsor
Altoida
Target Recruit Count
548
Registration Number
NCT02843529

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.